Treatment Parameters for Selective Occlusion of Experimental Corneal Neovascularization by Photodynamic Therapy using a Water Soluble Photosensitizer, ATX-S10(Na)

Topical Bevacizumab and Ocular Surface Neovascularization in Patients With Stevens-Johnson Syndrome

“…However, PDT requires the use of special laser equipment and photosensitizing agents that may not be widely available. 6,[27][28][29] In this report, we describe 3 eyes of 2 patients that underwent regression of SJS-associated OSN after a short course of topical bevacizumab.…”

New Drug Delivery for Corneal Neovascularization Using Polyion Complex Micelles

“…Preliminary studies of PDT in animal models of corneal NV have shown promising results. 12,13 According to Holzer et al, 13 PDT using benzoporphyrin (verteporfin) as a PS elicited successful regression of corneal vessels in rabbits. However, the optimal laser energy to induce long-term regression was 3 times higher than that used to treat choroidal NV, and the regression rate was approximately 50%.…”